ArticleBriefings in bioinformatics2025
scGGC: a two-stage strategy for single-cell clustering through cellular gene pathway construction.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
In the last few years, there has been great advancement in the field of single-cell data investigation, particularly in the development of clustering methods. The advanced research is increased for the development of clustering algorithms tailored for single-cell RNA sequencing data. Conventional methods primarily focus on local relationships among cells or genes, while overlooking the global cell-gene interactions. As a result, the high dimensionality, noise, and sparsity of the data continue to pose significant challenges to clustering accuracy. To address the challenges of single-cell clustering analysis, we propose a novel single-cell clustering model, scGGC, which integrates graph autoencoders and generative adversarial network techniques. The innovations of scGGC include two components: (i) construction of an adjacency matrix that incorporates cell-cell and cell-gene relationships to capture complex interactions in a graph structure, enabling nonlinear dimensionality reduction and initial clustering via a graph autoencoder; (ii) enhancement of clustering performance by selecting high-confidence samples from the initial clusters for adversarial neural network training. A comprehensive evaluation on nine publicly available scRNA-seq datasets demonstrates that scGGC outperforms eight comparison methods. For example, on datasets such as MHC3K, the Adjusted Rand Index increases by an average of 10.1%. Furthermore, marker gene identification and cell type annotation further confirm the biological relevance of scGGC, with marker gene overlap rates exceeding 70% across multiple datasets. We conclude that scGGC not only improves the accuracy of single-cell data clustering but also enhances the identification of cell-type-specific marker genes. The scGGC code is available at https://github.com/Zhi1002/scGGC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.